Topics

Gliomas | Diagnosis | Liquid biopsy

Home > Publications > Topics > Gliomas > Diagnosis > Liquid biopsy

2024

*Li K, Zhu Q, Yang J, Zheng Y, Du S, Song M, Peng Q, Yang R, Liu Y, Qi L.
Imaging and Liquid Biopsy for Distinguishing True Progression From Pseudoprogression in Gliomas, Current Advances and Challenges.
Acad Radiol. 2024 Apr 12:S1076-6332(24)00162-4. doi: 10.1016/j.acra.2024.03.019. PMID: 38614827. Review. ˍ

Mikolajewicz N, Yee PP, Bhanja D, Trifoi M, Miller AM, Metellus P, Bagley SJ, Balaj L, de Macedo Filho LJM, Zacharia BE, Aregawi D, Glantz M, Weller M, Ahluwalia MS, Kislinger T, Mansouri A.
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
J Clin Oncol. 2024 Apr 12:JCO2301621. doi: 10.1200/JCO.23.01621. PMID: 38608213. Review˰ ˍ

*Li K, Zhu Q, Yang J, Zheng Y, Du S, Song M, Peng Q, Yang R, Liu Y, Qi L.
Imaging and Liquid Biopsy for Distinguishing True Progression From Pseudoprogression in Gliomas, Current Advances and Challenges.
Acad Radiol. 2024 Apr 12:S1076-6332(24)00162-4. doi: 10.1016/j.acra.2024.03.019. PMID: 38614827. Review. ˍ

Huang T, Sun F, Gao K, Wang Y, Zhu G, Chen F.
The role of Peripheral Inflammatory Markers and Coagulation factors in patients with CNS immune disease and glioma.
World Neurosurg. 2024 May 17:S1878-8750(24)00843-X. doi: 10.1016/j.wneu.2024.05.080. PMID: 38763458. Observational study˰ ˍ

Papadimitrakis D, Perdikakis M, Gargalionis AN, Papavassiliou AG.
Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas.
Biomolecules. 2024 Jul 5;14(7):801. doi: 10.3390/biom14070801. PMID: 39062515. Review. ˍ

Li B, Gao B, Zhu HJ, Luwor RB, Lu J, Zhang L, Kong B.
The Prognostic Value of Preoperative Inflammatory Markers for Pathological Grading of Glioma Patients.
Technol Cancer Res Treat. 2024 Aug 5;23:15330338241273160. doi: 10.1177/15330338241273160. PMID: 39099463. Observational study. ˍ

Batool SM, Escobedo AK, Hsia T, Ekanayake E, Khanna SK, Gamblin AS, Zheng H, Skog J, Miller JJ, Stemmer-Rachamimov AO, Cahill DP, Balaj L, Carter BS.
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas.
Nat Commun. 2024 Aug 16;15(1):7074. doi: 10.1038/s41467-024-51332-7. PMID: 39152110. Observational study. ˍ

Detchou D, Barrie U.
Circulating biomarkers literature in glioma patient populations.
Neurosurg Rev. 2024 Aug 27;47(1):484. doi: 10.1007/s10143-024-02738-w. PMID: 39187709. Review˰ ˍ

**Löding S, Antti H, Sjöberg RL, Melin B, Björkblom B.
Blood based metabolic markers of glioma from pre-diagnosis to surgery.
Sci Rep. 2024 Sep 5;14(1):20680. doi: 10.1038/s41598-024-71375-6. PMID: 39237693. Observational study. ˍ

Zhou J, Tan B, Gao F.
Prognostic values of combined ratios of white blood cells in glioma: a systematic review and meta-analysis.
Neurosurg Rev. 2024 Oct 31;47(1):831. doi: 10.1007/s10143-024-03064-x. PMID: 39477886. Review; Meta-analysis˰ ˍ

Lu Y, Wang Z, Zhang D, Luo N, Yang H, Chen D, Huang H.
Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma.
Cell Mol Neurobiol. 2024 Dec 18;45(1):6. doi: 10.1007/s10571-024-01515-z. PMID: 39692767. Review. ˍ

Riviere-Cazaux C, Keough MB, Zuccato JA, Kumar R, Schulz S, Warrington AE, Ruff MW, Ellingson BM, Sanai N, Campian JL, Kizilbash SH, Parney IF, Zadeh G, Khasraw M, Kessler T, Sener U, Cahill DP, Mansouri A, Burns TC.
A Hitchhiker's Guide Toward CSF Biomarkers for Neuro-Oncology.
Neuro Oncol. 2024 Dec 30:noae276. doi: 10.1093/neuonc/noae276. PMID: 39786477. Review. ˍ

2025

Madlener S, Stepien N, Senfter D, Mayr L, Laemmerer A, Hedrich C, Baumgartner A, Lötsch-Gojo D, Sterba J, Pokorna P, Kiesel B, Widhalm G, Eckert F, Preusser M, Rössler K, Azizi A, Peyrl A, Czech T, Haberler C, Slavc I, Kasprian G, Dorfer C, Furtner J, Gojo J.
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method.
Acta Neuropathol. 2025 Jan 3;149(1):5. doi: 10.1007/s00401-024-02842-7. PMID: 39751690. Observational study. ˍ

Amjad A, Ali MR, Khalid M, Segawa F.
Liquid biopsies for early detection of gliomas: are we near a breakthrough?
Ann Med Surg (Lond). 2025 Sep 30;87(12):7862-7863. doi: 10.1097/MS9.0000000000003987. PMID: 41377322. Editorial. ˍ

Huang X, Guo J, Cui Y, Liang J, Cheng N, Zhang Y, He D.
Circulating tumor cells as a recurrence risk marker in glioma: a retrospective study.
Transl Cancer Res. 2025 Nov 26;14(11):8022-8031. doi: 10.21037/tcr-2025-1134. PMID: 41378039. Observational study. ˍ

2026

Pandey A, Datta A, Verma R, Jaiswal AK, Kumar R, Das KK, Baishya B.
Exploring metabolic signatures in urine using NMR for improved prognosis of gliomas.
Metabolomics. 2026 Mar 6;22(2):32. doi: 10.1007/s11306-026-02414-8. PMID: 41790324. ˍ

Amezquita-Contreras C, Bueno A, Arellano D, Ruvalcaba-Guerrero H, Johnson WE, Dono A, Esquenazi Y, Ballester LY.
Circulating tumor DNA as a liquid biopsy for glioma detection in cerebrospinal fluid and plasma: A systematic review and meta-analysis.
Neurooncol Adv. 2026 Sep 22;8(1):vdag253. doi: 10.1093/noajnl/vdag253. PMID: 42871623. ˍ